Incorporated in 1983, Suryalata Spinning Mills Ltd manufactures Synthetic Yarns suitable for suiting, shirting and knitting
The company operates in a highly fragmented and commoditized synthetic yarn market where competitive advantage is limited to cost efficiency through captive power. While the 15MW solar capacity provides a utility-cost edge over local peers, the lack of brand power or switching costs is reflected in the low net margins of 4.4%.
Management has prioritized vertical integration into renewable energy to protect margins from rising state power tariffs. Recent capital deployment has shifted toward higher-technology Vortex machinery to move up the value chain, though revenue growth remains sluggish at a 3% CAGR.
The investment collapsed as the company's thin 4.4% margins were obliterated by a combination of rising raw material costs and the permanent loss of state power incentives. Despite the 15MW solar investment, the lack of pricing power meant the company could not pass on inflationary pressures in a commoditized market. The stagnant 3% revenue growth eventually turned negative as more efficient global competitors undercut their Vortex-spun products, while the high concentration of promoter family members led to rigid decision-making that failed to pivot the business model before the capital was depleted.
RichFakir rates Suryalata Spinning Mills Ltd's business quality as poor — 37/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Suryalata Spinning Mills Ltd is trading about 48% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Suryalata Spinning Mills Ltd is: Not rated. A poor business at a cheap price — it does not make our shortlist right now.
RichFakir's educational estimate of Suryalata Spinning Mills Ltd's fair value is about ₹714 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →